2m 2m 2m 2m 2m 2m 2m
VERRICA PHARMA (VRCA)
NASDAQ
$4.36-$0.16 (-3.54%)
Price as of Oct 02, 2026 4:10 PM EDT- $77.6MMarket Cap
- -0.55%1-Year Change
- BiotechnologyIndustry
VERRICA PHARMA (VRCA)
$4.36-$0.16 (-3.54%)
VRCA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $4.51 | ||
Change | -$0.28 (-5.84%) | ||
Open | $4.85 | ||
High | $4.85 | ||
Low | $4.51 | ||
Previous Close | $4.79 | ||
Volume | 55,307 | ||
30-Day Average Volume | 49,435 | ||
1-Week Change | 3.56% | ||
1-Month Change | -13.84% | ||
1-Year Change | -0.55% | ||
3-Year Change | -88.38% | ||
5-Year Change | -96.39% | ||
Fundamentals | |||
Shares Outstanding | 17.2M | ||
Total Assets | $36.0M | ||
Market Cap | $77.6M | ||
Enterprise Value | $116.4M | ||
Period: QTR TTM FY | |||
Revenue | $5.1M | ||
Net Income | -$13.2M | ||
Free Cash Flow | -$9.3M | ||
EBIT | -$11.1M | ||
EBITDA | -$11.0M | ||
Net Working Capital | $10.2M | ||
EPS | -$0.62 | ||
Enterprise Value/EBITDA | -11 | ||
Enterprise Value/Revenue | 23 | ||
P/B | 18 | ||
P/E | -7 | ||
PEG | 0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 07/25/2025 | ||
Earnings & Revenue